Literature DB >> 17374562

Basal ganglia dopamine loss due to defect in purine recycling.

Kiyoshi Egami1, Silaja Yitta, Suhail Kasim, J Chris Lewers, Rosalinda C Roberts, Mohamed Lehar, H A Jinnah.   

Abstract

Several rare inherited disorders have provided valuable experiments of nature highlighting specific biological processes of particular importance to the survival or function of midbrain dopamine neurons. In both humans and mice, deficiency of hypoxanthine-guanine phosphoribosyl transferase (HPRT) is associated with profound loss of striatal dopamine, with relative preservation of other neurotransmitters. In the current studies of knockout mice, no morphological signs of abnormal development or degeneration were found in an exhaustive battery that included stereological and morphometric measures of midbrain dopamine neurons, electron microscopic studies of striatal axons and terminals, and stains for degeneration or gliosis. A novel culture model involving HPRT-deficient dopaminergic neurons also exhibited significant loss of dopamine without a morphological correlate. These results suggest that dopamine loss in HPRT deficiency has a biochemical rather than anatomical basis and imply that purine recycling to be a biochemical process of particular importance to the function of dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374562      PMCID: PMC1930158          DOI: 10.1016/j.nbd.2007.01.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

Review 1.  Mendelian disorders deserve more attention.

Authors:  Stylianos E Antonarakis; Jacques S Beckmann
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

2.  An improved cupric-silver method for impregnation of axonal and terminal degeneration.

Authors:  J S DeOlmos; W R Ingram
Journal:  Brain Res       Date:  1971-10-29       Impact factor: 3.252

3.  Importance of fixation in immunohistochemistry: use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase.

Authors:  A Berod; B K Hartman; J F Pujol
Journal:  J Histochem Cytochem       Date:  1981-07       Impact factor: 2.479

4.  Serum uric acid levels and the risk of Parkinson disease.

Authors:  Lonneke M L de Lau; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

5.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

Review 6.  The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases.

Authors:  H A Jinnah; L De Gregorio; J C Harris; W L Nyhan; J P O'Neill
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

7.  Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease.

Authors:  K Hyland; S Kasim; K Egami; L A Arnold; H A Jinnah
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

8.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

9.  Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.

Authors:  John W Haycock; Laurence Becker; Lee Ang; Yoshiaki Furukawa; Oleh Hornykiewicz; Stephen J Kish
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

10.  Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization.

Authors:  H A Jinnah; E J Hess; M C Wilson; F H Gage; T Friedmann
Journal:  Mol Cell Neurosci       Date:  1992-02       Impact factor: 4.314

View more
  24 in total

1.  Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Authors:  Maria G Zizzo; Monica Frinchi; Domenico Nuzzo; Hyder A Jinnah; Giuseppa Mudò; Daniele F Condorelli; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio; Flavia Mulè; Natale Belluardo; Rosa Serio
Journal:  Auton Neurosci       Date:  2017-12-20       Impact factor: 3.145

2.  MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease?

Authors:  Ghiabe-Henri Guibinga; Gorjan Hrustanovic; Kathryn Bouic; Hyder A Jinnah; Theodore Friedmann
Journal:  Hum Mol Genet       Date:  2011-10-31       Impact factor: 6.150

3.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.

Authors:  Martin Göttle; Heike Burhenne; Diane Sutcliffe; H A Jinnah
Journal:  J Neurochem       Date:  2013-08-18       Impact factor: 5.372

4.  Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Authors:  Eric B Dammer; Martin Göttle; Duc M Duong; John Hanfelt; Nicholas T Seyfried; H A Jinnah
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

5.  The basal ganglia and cerebellum interact in the expression of dystonic movement.

Authors:  Vladimir K Neychev; Xueliang Fan; V I Mitev; Ellen J Hess; H A Jinnah
Journal:  Brain       Date:  2008-07-26       Impact factor: 13.501

Review 6.  Attenuated variants of Lesch-Nyhan disease.

Authors:  H A Jinnah; Irene Ceballos-Picot; Rosa J Torres; Jasper E Visser; David J Schretlen; Alfonso Verdu; Laura E Laróvere; Chung-Jen Chen; Antonello Cossu; Chien-Hui Wu; Radhika Sampat; Shun-Jen Chang; Raquel Dodelson de Kremer; William Nyhan; James C Harris; Stephen G Reich; Juan G Puig
Journal:  Brain       Date:  2010-02-22       Impact factor: 13.501

7.  Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia.

Authors:  Chang-Hyun Song; Douglas Bernhard; Caroline Bolarinwa; Ellen J Hess; Yoland Smith; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-01-19       Impact factor: 5.996

8.  A new knock-in mouse model of l-DOPA-responsive dystonia.

Authors:  Samuel J Rose; Xin Y Yu; Ann K Heinzer; Porter Harrast; Xueliang Fan; Robert S Raike; Valerie B Thompson; Jean-Francois Pare; David Weinshenker; Yoland Smith; Hyder A Jinnah; Ellen J Hess
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

9.  Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis.

Authors:  Irene Ceballos-Picot; Lionel Mockel; Marie-Claude Potier; Luce Dauphinot; Thomas L Shirley; Raoul Torero-Ibad; Julia Fuchs; H A Jinnah
Journal:  Hum Mol Genet       Date:  2009-04-02       Impact factor: 6.150

Review 10.  Emerging common molecular pathways for primary dystonia.

Authors:  Mark S Ledoux; William T Dauer; Thomas T Warner
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.